Financial Crossroads | Splash Beverage Group faces critical challenges with weak financial health, yet shows potential for turnaround through new funding and strategic initiatives |
Acquisition Ambitions | Explore SBEV's plans to acquire Western Son Vodka, a move expected to boost revenue and operational efficiencies, reshaping the company's market position |
Analyst Outlook | H.C. Wainwright & Co. maintains a Buy rating with a $1.00 price target, reflecting cautious optimism amid SBEV's transformation efforts |
Growth Projections | Delve into SBEV's ambitious targets: $38-40 million revenue by 2025 with positive EBITDA, contingent on successful strategy execution and market dynamics |
Metrics to compare | EDVA | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipEDVAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.1x | −0.8x | 11.5x | |
PEG Ratio | 0.00 | 0.01 | 0.03 | |
Price/Book | −0.1x | 4.5x | 1.5x | |
Price / LTM Sales | 59.9x | 1.8x | 0.9x | |
Upside (Analyst Target) | - | 40.8% | 22.4% | |
Fair Value Upside | Unlock | 0.8% | 12.4% | Unlock |
Endovia Health Sciences, Inc. engages in the manufacturing, distribution, marketing, and sale of various beverages in the United States. It operates in two segments Manufacture and Distribution of Non-Alcoholic and Alcoholic Beverages, and Retail Sale of Beverages and Groceries Online. The company offers flavored tequilas under the Chispo Tequila brand name; wine under the Copa DI Vino brand name; and sangria under the Pulpoloco Sangria brand name. It distributes its products through the business-to-business and business-to-consumer e-commerce distribution platform. The company was formerly known as Splash Beverage Group, Inc. and changed its name to Endovia Health Sciences, Inc. in August 2026. The company is based in Fort Lauderdale, Florida.